Summary

This testimony discusses the status of agencies' efforts to establish effective internal control over federal medical stockpiles that can be used to treat civilian and military victims in the event of a chemical or biological attack. In earlier reports, GAO recommended that federal agencies strengthen their management of these medical stockpiles. GAO found that these agencies have made significant progress toward implementing its recommendations. Management at each of the responsible agencies has given priority to and placed emphasis on strengthening internal control over stockpiles. As a result, inventory discrepancy rates and accountability have been reduced.